Popular Articles

McGill University Receives Almost $63 Million Under CFI Program To Support Five Research Projects
Dr. Denis Therien, Vice-Principal (Research and International Relations) of McGill University has welcomed the Canada Foundation for Innovation"s (CFI) investment of $32,649,184 supporting five projects led by Dr. David Plant, Dr. Paul Lasko, Dr. David Thomas, Dr. Vincent Giguç¨re and Dr. Chao-Jin (C.J.) Li. The Quebec government also confirmed it would match that funding.
pharmacy online
GOP Returns Fire On Comp Effectiveness, Health Reform
"GOP Senate Leader Mitch McConnell, Ky., GOP Senate Whip Jon Kyl, Ariz., Senate Republican Conference Chairman Lamar Alexander, Tenn., and House Republican Conference Chairman Mike Pence, Ind., went on the offensive following Obama"s speech in Chicago to the American Medical Association. Kyl and McConnell unveiled a bill to rival the Democratic bill, while Alexander and Pence spoke to reporters," according to the Hill. "Pence, who said he did not watch Obama"s speech, said House Republicans would try to force amendments to the bill and would vote "no" on the bill otherwise because it improperly pits the government against private insurers. He and Alexander both said such a government role would eventually prompt employers to reduce the plans they offer employees."
News of the day
Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers
Epeius Biotechnologies stuns the medical and scientific communities with a dramatic demonstration of single-agent efficacy with its lead product, Rexin-G, for metastatic cancer. The landmark article (accessible online as of June 16, 2009 in Molecular Therapy, the Official Journal of The American Society of Gene Therapy, documents the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out and destroy metastatic cancers that have spread throughout the body, while sparing normal cells and healthy tissues and organs. Following the FDA"s designation of Rexin-G as an Orphan Drug for the treatment of soft tissue sarcoma and osteosarcoma in 2008, the results of these two independent studies represent a major step toward gaining Accelerated Approval of Rexin-G for osteosarcoma in the United States.
Nutrition

Frontal Cerebral Hypothermia Found To Be Possible New Treatment For Insomnia

Insomnia is associated with increased frontal cerebral metabolism during Rapid Eye Movement (REM) sleep. Cerebral hypothermia, or cooling of the brain, has been found to reduce cerebral metabolism in other medical conditions, but its effects in insomnia are unknown. In a University of Pittsburgh study by Eric Nofzinger, M.D., professor of psychiatry, patients with insomnia who received a mild hypothermic stimulus to their scalps an hour before bedtime and during the first REM cycle of sleep showed reduced brain metabolism in the frontal cortex and reduced core body temperature. Three-quarters of the patients also reported other benefits such as less distracting thoughts before bedtime and an overall better and more refreshing sleep. Dr. Nofzinger notes that further clinical trials are necessary to determine the efficiency of this treatment for chronic insomnia. University of Pittsburgh


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):